U.S. COMPANY FILING
ALNYLAM PHARMACEUTICALS, INC. — Form 8-K filed 2026-02-12
Filing text preview
Alnylam Pharmaceuticals filed an 8-K on February 12, 2026, announcing its Q4 2025 financial results. The press release is furnished as Exhibit 99.1 and is not deemed filed.
This preview uses text already stored in ReportGem and does not fetch the document from object storage during SEO generation. Review the internal filing record and the official SEC source before relying on it.
Open filing record